BioMedWire Stocks

At Least 14 Million Americans Affected by Data Breaches in Healthcare

A brief generated by a cybersecurity company has revealed that nearly 14 million patients in the United States have been affected by breaches in healthcare data thus far this year. The report also found that 91% of the breaches involved ransomware, which calls attention to the targeting of the country’s healthcare sector.

SonicWall based the report it generated on data from Capture Labs, which utilizes machine learning to gather and retain data on threats and attack vectors in real time.

The researchers’ analysis highlighted an increasing prominence of ransomware actors that specialized in targeting healthcare, such as ALPHV/BlackCat and LockBit. The former actor revealed it was responsible for attacking Change Healthcare earlier this year, which led to a huge data breach and millions in ransom payments.

The threat brief also underscored the frequency with which these actors exploited the critical vulnerabilities of organizations, with data suggesting that 60% of the vulnerabilities used targeted MS Exchange, a tool that is widely used in this sector. For instance, ransomware groups were found to be exploiting ProxyLogon and ProxyShell Exploit Chain vulnerabilities to obtain access to servers and introduce ransomware.

The analysis even found that sometimes the vulnerabilities are chained together to strengthen the attack.

The PaperCut and Citrix Bleed vulnerabilities are also targeted in the healthcare sector, with the researchers noting that the reactive patching of vulnerabilities or their remaining unpatched make healthcare organizations even more vulnerable to exploitation.

In their conclusion, the researchers explained that the adoption of artificial intelligence and digital tools during and after the coronavirus pandemic had increased the attack surface of healthcare organizations. They revealed that their analysis found that a considerable increase in ransomware attacks that targeted the healthcare industry had been observed since 2022. They then added that healthcare was a primary target for exploitation by cyberthreat actors because of its reliance on sensitive information and data-driven nature.

In addition, the researchers suggested that organizations implement a proactive and multilayered approach to defend themselves against these mounting threats. Continuous monitoring, strong authentication protocols and an even stronger program to manage patches could aid organizations in protecting patient data while alleviating the risk of data breaches.

This isn’t the first company to investigate the increasing threat of data breaches and ransomware in this sector either, as different government entities and private cybersecurity companies have done similar investigations.

Last year, the Office for Civil Rights under Health and Human Services revealed that they had recorded a 278% surge in ransomware. The office also recorded a 239% rise in breaches reported, most of them involving hacking.

These figures sound a warning that enterprises that specialize in leveraging healthcare data, such as HealthLynked Corp. (OTCQB: HLYK), need to heed and constantly improve their security systems so that cyber threats can be thwarted in advance.

NOTE TO INVESTORS: The latest news and updates relating to HealthLynked Corp. (OTCQB: HLYK) are available in the company’s newsroom at https://ibn.fm/HLYK

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Surgeon, Payer, Patient Win: The Economic and Workflow Advantages Positioning GelrinC as a New Standard of Care for Knee Cartilage Repair

Regentis recently received European regulatory approval for a next-generation GelrinC manufacturing process that increases production…

6 hours ago

VERAXA Biotech AG (NASDAQ: VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies 

The company has advanced its VXA-222 bispecific antibody-drug conjugate (“bsADC”) program into the next stage…

12 hours ago

As Cases of Measles Rise, US Officials Double Down on Contact Tracing and Vaccination

As July came to an end, the United States reached an undesirable milestone: exceeding the…

1 day ago

Climate Change is Accelerating the Spread of Infectious Diseases, Experts Warn

Scientists and public health experts are warning that climate change is accelerating the rate at which infectious…

5 days ago

Novel Vitamin B12 Treatment Offers Hope in Brain Cancer Treatment

Glioblastoma multiforme (GBM) is the deadliest type of brain cancer and patients usually die within 15 months…

6 days ago

VERAXA Biotech AG (NASDAQ: VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform

The company has appointed antibody therapeutics specialist Dr. Christoph Erkel as Chief Scientific Officer. The…

1 week ago